zolpidem tartrate

FDA Drug Profile — ZOLPIDEM TARTRATE, zolpidem tartrate, Zolpidem Tartrate, Ambien CR, Ambien

zolpidem tartrate is listed in the FDA National Drug Code directory with 61 NDC codes, marketed under brand names including ZOLPIDEM TARTRATE, zolpidem tartrate, Zolpidem Tartrate. Available dosage forms: tablet, tablet, coated, tablet, film coated, tablet, film coated, extended release, capsule.

Drug details

Generic Name
zolpidem tartrate
Brand Names
ZOLPIDEM TARTRATE, zolpidem tartrate, Zolpidem Tartrate, Ambien CR, Ambien
Application Number
ANDA077903
Sponsor
Torrent Pharmaceuticals Limited
NDC Codes
61
Dosage Forms
TABLET, TABLET, COATED, TABLET, FILM COATED, TABLET, FILM COATED, EXTENDED RELEASE, CAPSULE
Routes
ORAL, SUBLINGUAL
Active Ingredients
ZOLPIDEM TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE Zolpidem tartrate tablets, USP a gamma-amino butyric acid (GABA) A receptor positive modulator, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate tablets, USP are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate tablets, USP have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [ see Clinical Studies (14) ] . The clinical trials performed in support of efficacy were 4 to 5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.